Status
Conditions
Treatments
About
Osteomyelitis is described as infection and inflammation of the long bone or bone marrow, often due to an open wound, operation, or invasive trauma.1 It is invasive and involves hematogenous seeding or contiguous spread of the infectious organism
Full description
This disease can be classified by location of infection, extent of spread, chronicity, and source of infection.3,4 Osteomyelitis can be caused by a variety of organisms, most commonly gram-positive staphylococci.
Osteomyelitis is associated with a high rate of relapse, high disease burden, and high health care costs.3 Following confirmation of disease via imaging and histopathologic examination, treatment consists of antibiotic therapy and, often, surgical intervention.3,5,6 Treatment with antibiotic therapy is often administered for 4-6 weeks when surgical intervention is not performed.6 Antibiotic selection should be guided by microbiology and antimicrobial susceptibilities.4 Thirty to sixty percent of osteomyelitis cases are caused by Staphylococcus aureus.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
• Admission to any MHS hospital between April 1, 2017 and April 1, 2023
Exclusion criteria
• IV antibiotics for less than 24 hours inpatient
Loading...
Central trial contact
Colette Ngo Ndjom, MS; Bethany Brauer, MPH
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal